Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees

Due to the rapid global spread of the Omicron (B.1.1.529) variant, efforts to scale up COVID-19 booster vaccination have been improved, especially in light of the increasing evidence of reduced neutralizing antibody (NT Ab) over time in vaccinated subjects. In this study, neutralizing antibody respo...

Full description

Bibliographic Details
Main Authors: Gabriele Anichini, Chiara Terrosi, Claudia Gandolfo, Gianni Gori Savellini, Simonetta Fabrizi, Giovanni Battista Miceli, Federico Franchi, Maria Grazia Cusi
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Vaccines
Subjects:
SARS-CoV-2
Omicron
mRNA vaccine
BNT162b2
mRNA-1273
Online Access:https://www.mdpi.com/2076-393X/10/5/808

Internet

https://www.mdpi.com/2076-393X/10/5/808

Similar Items